Laura Davisson, who directs the weight management programs at the West Virginia University Health System and oversaw care for hundreds of patients in the pilot program, told CBS News that GLP-1 drugs are "absolutely a game-changer." But in March, the state insurance agency funding the West Virginia program announced it was over, saying there was not enough supply and it was too expensive
Breaking this cycle early with steady, intentional hydration is key
Both are FDA-approved weekly injectable weight loss medications
Since it involves compounded medications that are not FDA-approved, working with a licensed provider is essential to ensure safety and appropriate dosing
At the National Institute on Drug Abuse (NIDA), we have worked on and support preclinical studies that explore this phenomenon, including one study that suggests GLP-1 agonists tamp down addicted rats appetites for cocaine
For many patients, the answer will be yes the medication is bioequivalent, the injection device is comparable, and the cost savings are real